CCL Products Intrinsic Value
CCL Products (CCL) median intrinsic value is ₹2131.20 from 10 valuation models (range ₹320–₹2664), vs current price ₹1065.60 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit CCL Products stock price NSE.
CCL Valuation Methods Summary — DCF, Graham Number & P/E
CCL Products intrinsic value across 10 models vs current price ₹1065.60 — upside/downside and value range per method. Check CCL Products market cap to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹860.00 | ₹688.00 - ₹1032.00 | -19.3% | EPS: ₹34.40, Sector P/E: 25x |
| Book Value Method | asset | ₹2171.30 | ₹1954.17 - ₹2388.43 | +103.8% | Book Value/Share: ₹868.52, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2131.20 | ₹1918.08 - ₹2344.32 | +100.0% | Revenue/Share: ₹1816.30, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹2131.20 | ₹1918.08 - ₹2344.32 | +100.0% | EBITDA: ₹776.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹2664.00 | ₹2131.20 - ₹3196.80 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹319.68 | ₹287.71 - ₹351.65 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹637.78 | ₹574.00 - ₹701.56 | -40.1% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹2131.20 | ₹1918.08 - ₹2344.32 | +100.0% | ROE: 19.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹819.90 | ₹737.91 - ₹901.89 | -23.1% | EPS: ₹34.40, BVPS: ₹868.52 |
| Dividend Yield Method | dividend | ₹319.68 | ₹287.71 - ₹351.65 | -70.0% | DPS: ₹5.75, Target Yield: 3.0% |
CCL Intrinsic Value vs Market Price — All Valuation Models
CCL Products fair value range ₹320–₹2664 vs current market price ₹1065.60 across 10 valuation models. See CCL P/B ratio history to compare market price against book value per share.
CCL Intrinsic Value Analysis — Undervalued or Overvalued?
CCL Products median intrinsic value ₹2131.20, current price ₹1065.60 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of CCL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of CCL Products (CCL) is ₹2131.20 (median value). With the current market price of ₹1065.60, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹319.68 to ₹2664.00, indicating ₹319.68 - ₹2664.00.
Is CCL undervalued or overvalued?
Based on our multi-method analysis, CCL Products (CCL) appears to be trading below calculated value by approximately 100.0%.
CCL Financial Health — Key Ratios vs Industry Benchmarks
CCL Products financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.45 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 19.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.13x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CCL Cash Flow Quality — Operating & Free Cash Flow
CCL Products operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹858 Cr | ₹858 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹290 Cr | ₹83 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹55 Cr | ₹-209 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹173 Cr | ₹20 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹116 Cr | ₹20 Cr | Positive Free Cash Flow | 7/10 |